Background: Orthostatic hypotension (OH) is a common underdiagnosed condition characterized by a fall in systolic or diastolic blood pressure (BP). There is some uncertainty about the minimum duration needed to detect OH beyond 3 min (delayed OH). We aimed to define a minimum time range for measurement of delayed OH in subjects referred to as tilt testing. Methods: A repeated measurements study Tel-Aviv Medical Center, on 692 subjects who underwent prolonged (40 min, vertical position) drug-free tilt testing. Survival curves were used to study time to an OH event; logistic regression to study factors associated with delayed OH and mixed models to study the pattern of repeated BP measures. Results: In our sample, 17% had OH within 3 min, 35% within 30 min, and 40% within 40 min. Among the 270 OH patients, 43 and 91% were identified within 3 and 30 min, respectively. Delayed OH was associated with female gender (OR = 1.95, 1.16-3.27) and age <65 years (OR = 2.17, 1.24-3.80). Older patients differed significantly from younger patients in BP pattern changes and had a higher rate of a fall in systolic BP. Conclusion: Tilt testing for 30 min identifies most cases of delayed OH in older patients, while those younger than 65 years need 10 min longer.

1.
Lanier JB, Mote MB, Clay EC: Evaluation and management of orthostatic hypotension. Am Fam Physician 2011;84:527-536.
2.
Low PA: Prevalence of orthostatic hypotension. Clin Auton Res 2008;18(suppl 1):8-13.
3.
Figueroa JJ, Basford JR, Low PA: Preventing and treating orthostatic hypotension: as easy as A, B, C. Cleve Clin J Med 2010;77:298-306.
4.
Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 1996;46:1470.
5.
Freeman R, Wieling W, Axelrod FB, et al: Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci 2011;161:46-48.
6.
Low PA, Tomalia VA, Park KJ: Autonomic function tests: some clinical applications. J Clin Neurol 2013;9:1-8.
7.
Gehrking JA, Hines SM, Benrud-Larson LM, et al: What is the minimum duration of head-up tilt necessary to detect orthostatic hypotension? Clin Auton Res 2005;15:71-75.
8.
Cheshire WP Jr, Phillips LH 2nd: Delayed orthostatic hypotension: is it worth the wait? Neurology 2006;67:8-9.
9.
Gibbons CH, Freeman R: Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology 2006;67:28-32.
10.
Rutan GH, Hermanson B, Bild DE, et al: Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension 1992;19:508-519.
11.
Low PA, Singer W: Management of neurogenic orthostatic hypotension: an update Lancet Neurol 2008;7:451-458.
12.
Figueroa JJ, Basford JR, low PA, et al: Preventing and treating orthostatic hypotension: as easy as A, B, C Cleve Clin J Med 2010;77:298-306.
13.
Duron E, Lenoir H, Pequignot R, et al: [What is the most relevant definition of orthostatic hypotension: systolic blood pressure drop, diastolic blood pressure drop, or both?]. Arch Mal Coeur Vaiss 2007;100:689-694.
14.
Alli C, Avanzini F, Bettelli G, et al: Prevalence and variability of orthostatic hypotension in the elderly. Results of the ‘Italian study on blood pressure in the elderly (SPAA)'. The ‘Gruppo di Studio Sulla Pressione Arteriosa nell'Anziano'. Eur Heart J 1992;13:178-182.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.